SYRA: Rasio silihan jangka dawa marang modal syrahealth.com

Syra Health Corp. (SYRA) is developing digital services and staffing solutions through US government contracts, as demonstrated by the price visualization available on the page. The company is implementing predictive analytics for citizen health monitoring to reduce disease risks. Additionally, the business relies on growing municipal demand for mental monitoring platforms, with the current metric standing at 0.00.

Syra Health Corporation (SYRA) - Utang jangka dawa marang ekuitas saka 21.02.2024 nganti 31.05.2025

This ratio determines the company's degree of financial autonomy by analyzing its long-term credit load. The dynamics of long-term liabilities to equity reflect the balance between debt financing and internal resources. The metric is calculated as the ratio of liabilities with a maturity of more than one year to the total amount of equity. For Syra Health Corp. (SYRA), this indicator demonstrates the ability to scale IT infrastructure and implement AI automation without critical dependence on external creditors. Optimizing this ratio confirms the sustainability of the strategy for the robotization of medical monitoring.

Perusahaan pesaing

Veeva Systems (VEEV) - Rasio tanggungan utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas DOCS (Doximity Corp)|Rasio silihan jangka dawa marang modal HQY|Waystar Holding Corp. - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal CRVL|PRVA - Utang jangka dawa marang ekuitas|Huron Consulting Group Inc. (HURN) - Rasio utang jangka dawa marang ekuitas|CERT: Utang jangka dawa marang modal|Kewajiban jangka dawa marang modal Omnicell Health (OMCL)|GDRX (GoodRx Holdings, Inc.) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang modal SDGR (schrodinger.com)|Utang jangka dawa marang ekuitas Phreesia (PHR)|Rasio tanggungan utang jangka dawa marang modal Omada Health, Inc.|Evolent - Rasio utang jangka dawa marang ekuitas|HealthStream Learning (HSTM) - Kewajiban jangka dawa marang modal|DH - Utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal CCSI (consensus.com)|AGL: Utang jangka dawa marang modal|Absci Corp (ABSI) - Utang jangka dawa marang modal|Rasio utang jangka dawa marang ekuitas SY|NRC: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal SPOK|OPRX (optimizerx.com) - Koefisien utang jangka dawa marang modal|Utang jangka dawa marang modal TBRG (TruBridge)|Simulations Plus Inc (SLP) - Kewajiban jangka dawa marang modal|SOPHiA GENETICS S.A. - Utang jangka dawa marang modal|HCAT - Utang jangka dawa marang modal|carecloud.com (CCLD) - Utang jangka dawa marang ekuitas|RSSS (researchsolutions.com) - Utang jangka dawa marang ekuitas|Rasio utang jangka dawa marang ekuitas DLHC|ONMD (OneMedNet Corp.) - Rasio silihan jangka dawa marang modal|Utang jangka dawa marang modal SCNX|HCTI (Healthcare Triangle Corporation) - Koefisien utang jangka dawa marang modal|iSpecimen - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka dawa marang modal BFRG|SCWorx - Utang jangka dawa marang modal|MSP Recovery Inc. (MSPR) - Rasio utang jangka dawa marang ekuitas|icoreconnect.com (ICCT) - Utang jangka dawa marang ekuitas|Kewajiban jangka dawa marang modal TRxADE Health Corp (MEDS)|Utang jangka dawa marang ekuitas Orgenesis Inc.|RCM: Koefisien utang jangka dawa marang modal|Utang jangka dawa marang ekuitas Sharecare (SHCR)|STRM: Kewajiban jangka dawa marang ekuitas|Apollo Medical Holdings, Inc. - Rasio utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka dawa marang modal Model N Corporation (MODN)|NXGN - Utang jangka dawa marang ekuitas